menu
    • menu

    Company profile for Orum Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Orum Therapeutics is combining the precision of antibodies with the power of targeted protein degraders to bring new medicines to patients with unmet medical needs. Orum (오름) means ‘ascent’ in Korean, climbing or moving upwards. Our vision is a world where no patient suffers from diseases caused by undruggable targets. Orum’s antibody platform can intracellularly deliver an active antibody therapeutic or payload, i...
    Orum Therapeutics is combining the precision of antibodies with the power of targeted protein degraders to bring new medicines to patients with unmet medical needs. Orum (오름) means ‘ascent’ in Korean, climbing or moving upwards. Our vision is a world where no patient suffers from diseases caused by undruggable targets. Orum’s antibody platform can intracellularly deliver an active antibody therapeutic or payload, is easily adaptable to target different cell types and intracellular proteins, and does not require chemical modification.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Orum TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    20 Acorn Park Drive Ste 501 Cambridge, MA 02140
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.orumrx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/orum-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Orum Therapeutics Presents ORM-1153 Preclinical Data at ASH 2025
    Orum Therapeutics Presents ORM-1153 Preclinical Data at ASH 2025

    03 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251103001400/en/Orum-Therapeutics-Announces-Presentation-of-Preclinical-Data-for-ORM-1153-at-the-2025-American-Society-of-Hematology-ASH-Annual-Meeting

    BUSINESSWIRE
    03 Nov 2025
    Share Share
    Orum Names Dorin Toader to Lead Degrader–Antibody Platforms
    Orum Names Dorin Toader to Lead Degrader–Antibody Platforms

    15 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-15/orum-therapeutics-appoints-dr-dorin-toader-as-head-of-platform-technology-to-advance-orum-s-degrade

    PHARMIWEB
    15 Oct 2025
    Share Share
    Orum Therapeutics Submits Registration Statement for KOSDAQ Listing
    Orum Therapeutics Submits Registration Statement for KOSDAQ Listing

    02 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241001144528/en

    BUSINESSWIRE
    02 Oct 2024
    Share Share
    Vertex mines for more gene editing riches with $15M Orum licensing deal
    Vertex mines for more gene editing riches with $15M Orum licensing deal

    17 Jul 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/vertex-mines-riches-15-million-orum-licensing-deal

    FIERCE BIOTECH
    17 Jul 2024
    Share Share
    Orum Therapeutics And Vertex Sign Multi-Target License Agreement
    Orum Therapeutics And Vertex Sign Multi-Target License Agreement

    16 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240716475713/en

    BUSINESSWIRE
    16 Jul 2024
    Share Share
    Bristol Myers buys Orum's blood cancer therapy for up to $180 mln
    Bristol Myers buys Orum's blood cancer therapy for up to $180 mln

    07 Nov 2023

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/bristol-myers-buys-orums-blood-cancer-therapy-up-180-mln-2023-11-06/

    REUTERS
    07 Nov 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search